Estimates Revisions Sartorius AG OTC Markets
Stocks
SSSGY
US80385Q1094
Advanced Medical Equipment & Technology
|
Delayed
OTC Markets
14:19:49 2026-06-03 EDT
|
5-day change | 1st Jan Change | ||
| 43.93 USD | -0.03% |
|
-.--% | +1.38% |
| 04:14am | UBS says Sartorius is poised for a demand boost and faster growth | DP |
| 02:35am | Buy ratings lift Sartorius and Stedim Biotech | DP |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Stocks
- SRT3 Stock
- SSSGY Stock
- Consensus Sartorius AG
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
